Roth/MKM Starts Reviva Pharmaceuticals (RVPH) at Buy, 'Antipsychotic with Blockbuster Potential'
Tweet Send to a Friend
(Updated - September 20, 2023 5:18 AM EDT)
Roth/MKM analyst Scott Henry initiates coverage on Reviva Pharmaceuticals (NASDAQ: RVPH) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth/MKM analyst Scott Henry initiates coverage on Reviva Pharmaceuticals (NASDAQ: RVPH) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
